Page 150 - SAMRC Annual Report 2024-2025
P. 150

Platform for

                                                               Pharmacogenomics
                                                               Research and Translation
                                                               Research Unit




                                                               Unit director:
                                                               Prof. Collet Dandara
                                                               collet.dandara@uct.ac.za




            Advancing Research Priorities:                     with HIV. Five members of the Unit presented their
            Strategic Objectives and Impact                    research findings at the African Society for Human
                                                               Genetics Conference in Uganda (3-7 Feb 2025).
            The SAMRC/UCT Pharmacogenomics Research and
            Translation Unit (PREMED) strategic objective is to   Building Capacity Through
            bring the promise of pharmacogenomics (PGx), on
            the use of a patient's genetic information to guide   Training, Mentorship, and Support
            optimal drug therapy and dose, which enables       The research within the PREMED unit has resulted
            prediction of drug response by translating known   in capacity building at different levels. In terms of
            findings among African patients.                   training students in the reporting period of 2024/25,
                                                               PREMED  has  trained  and  graduated  3  Honours
            One of the objectives of PREMED is to catalyse the   students (awaiting graduation), 4 MSc students
            translation of research findings. The objective is to   who graduated in September 2024, 4 current MSc
            create awareness among the public and policymakers   students, and 4 PhD students, and 1 Postdoc. Every
            on the importance of pharmacogenomics for          effort is being made to continue recruiting students
            its eventual acceptance and uptake. Translating    from  disadvantaged  backgrounds  and  female
            pharmacogenomics  research  findings  will  lead   students.
            to better future  outcomes  for  both patients and
            healthcare providers through improved medication   The proposed research under the pharmaco-
            safety and efficacy.                               genomics platform, PREMED, brings together
                                                               researchers working on pharmacokinetics, pharma-
            Key Milestones and Achievements                    cogenetics,  pharmacogenomics,  pharmacomicro-
                                                               biomics, and cell biology, to unleash this diverse
            Dyslipidaemia results of over 1000 samples were    expertise on research that will improve the use of
            sequenced and analysed, currently the team is      therapeutic drugs.
            analysing and interpreting data. The unit successfully
            received postdoctoral funding from SAMRC to host   Navigating the Impact of US
            one postdoc in our unit. The postdoctoral fellow
            will work on translation, this will contribute to the   Executive Orders on Funding.
            genetic screening of key pharmacogenomics genes    Has discouraged us from applying for NIH funding.
            in the clinical settings. Ultimately it will contribute
            toward better management of our patients.          Research Translation

            On a mentorship scale, one of the members          Through Arts and Science
            (Dr  K Mnika)  received  the Africa  Oxford Initiative   The  research  findings  are  communicated  to  a
            Fellowship for 2024/2025, this is key for the unit to   bigger audience by providing the opportunity to
            promote international collaboration. Dr N Soko     students to present the research findings at local or
            received  a small grant,  Pilot  Funding for  Research   international conferences, and publication of articles
            on Infection-Related Cancers among People Living   in research journals. The work is also shared through



            148         SAMRC  ANNUAL REPOR T 2024-25
   145   146   147   148   149   150   151   152   153   154   155